Tuesday 26 November 2024
12:30
Prof Sir John Bell
The Ellison Institute of Technology
John joins us to tell us more about the Ellison Institute of Technology’s mission to develop and deploy technology in pursuit of solving some of humanity’s most challenging and enduring problems. Guided by world leaders, scientists and entrepreneurs, EIT seeks to accelerate innovation in health and medical science, food security and sustainable agriculture, climate change and clean energy, and government innovation and era of artificial intelligence.
Sir John leads multi-disciplinary teams at EIT Oxford – a major new interdisciplinary research and development facility that will support EIT’s mission to develop and deploy technology in pursuit of solving humanity’s most challenging and enduring problems. He served as Regius Professor of Medicine at the University of Oxford from 2002 to 2024. His extensive research interests span the areas of autoimmune disease, immunology and genetics. He was crucial in creating Genomics England, UK Biobank and Our Future Health and has advised multiple Ministers and Prime Ministers in the UK government, including during the Covid epidemic when he played a major role in the development and roll out of the Oxford-AstraZeneca Covid-19 vaccine. Sir John was President of the Academy of Medical Sciences from 2006 to 2011 and elected Fellow of the Royal Society and honorary Fellow of the Royal Academy of Engineering.
President, Ellison Institute of Technology Oxford; Co-CEO EIT Global
Sir John leads multi-disciplinary teams at EIT Oxford – a major new interdisciplinary research and development facility that will support EIT’s mission to develop and deploy technology in pursuit of solving humanity’s most challenging and enduring problems. He served as Regius Professor of Medicine at the University of Oxford from 2002 to 2024. His extensive research interests span the areas of autoimmune disease, immunology and genetics. He was crucial in creating Genomics England, UK Biobank and Our Future Health and has advised multiple Ministers and Prime Ministers in the UK government, including during the Covid epidemic when he played a major role in the development and roll out of the Oxford-AstraZeneca Covid-19 vaccine. Sir John was President of the Academy of Medical Sciences from 2006 to 2011 and elected Fellow of the Royal Society and honorary Fellow of the Royal Academy of Engineering.
